Table 4 Comparison of effects of SCRA and cannabis use as reported by 154 participants undergoing treatment for cannabis use in New South Wales, Australia
| Self-reported effects/experiencesa |
SCRAs (%) (n = 82) |
Cannabis (%) (n = 72) | OR | 95% CI |
McNemar Test p-value |
|---|---|---|---|---|---|
| Racing heart/irregular heartbeat | 40.2 | 9.8 | 4.1 | 1.9–8.9 | < 0.001 |
| Nausea | 37.8 | 9.8 | 3.9 | 1.8–8.4 | < 0.001 |
| Panic | 37.8 | 17.1 | 2.2 | 1.1–4.2 | 0.016 |
| Dizziness | 35.4 | 9.8 | 3.6 | 1.7–8.0 | 0.001 |
| Excessive Sweatiness | 31.7 | 9.8 | 3.3 | 1.5–7.2 | 0.003 |
| Hangover effect | 31.7 | 12.2 | 2.6 | 1.3–5.4 | 0.011 |
| Dream-like state | 31.7 | 22.0 | 1.4 | 0.8–2.6 | 0.291 |
| Chest pain | 28.0 | 8.5 | 3.3 | 1.4–7.7 | 0.005 |
| Hallucinations | 28.0 | 7.3 | 3.8 | 1.6–9.4 | 0.002 |
| Decreased appetite | 25.6 | 15.9 | 1.6 | 0.8–3.2 | 0.229 |
| Light headedness | 24.4 | 11.0 | 2.2 | 1.0–4.9 | 0.061 |
| Confusion/disorientation | 24.4 | 9.8 | 2.5 | 1.1–5.7 | 0.036 |
| Psychotic experiences | 20.7 | 8.5 | 2.4 | 1.0–5.9 | 0.064 |
| Headache | 20.7 | 11.0 | 1.9 | 0.8–4.2 | 0.169 |
| Paranoia | 19.5 | 13.4 | 1.5 | 0.7–3.1 | 0.442 |
| Decreased motor coordination | 19.5 | 12.2 | 1.6 | 0.7–3.5 | 0.327 |
| Decreased ability to function after use | 18.3 | 15.9 | 1.2 | 0.6–2.4 | 0.851 |
| Nervousness or anxiety | 18.3 | 12.2 | 1.5 | 0.7–3.4 | 0.424 |
| Feelings of personal isolation | 18.3 | 14.6 | 1.3 | 0.6–2.7 | 0.701 |
| Nausea or vomiting | 18.3 | 19.5 | 0.9 | 0.5–1.9 | 1.000 |
| Passed out after use of SCRAs | 17.1 | 14.6 | 1.2 | 0.5–2.5 | 0.845 |
| Felt antisocial after smoking | 17.1 | 13.4 | 1.3 | 0.6–2.8 | 0.690 |
| Slurred Speech | 17.1 | 11.0 | 1.6 | 0.7–3.6 | 0.405 |
| Ringing in the ears | 17.1 | 12.2 | 1.4 | 0.6–3.2 | 0.541 |
| Worried about meeting strangers | 15.9 | 11.0 | 1.4 | 0.6–3.4 | 0.523 |
| Depression | 13.6 | 19.8 | 0.7 | 0.3–1.5 | 0.442 |
| Convulsions | 12.2 | 4.9 | 2.5 | 0.8–8.0 | 0.180 |
| Feel more energetic | 11.0 | 34.1 | 0.3 | 0.2–0.7 | 0.003 |
| Increased ability to function after use | 8.5 | 43.9 | 0.2 | 0.1–0.4 | < 0.001 |
| Felt sluggish/heavy | 7.3 | 18.3 | 0.4 | 0.2–1.0 | 0.078 |
| Clumsy | 6.1 | 24.4 | 0.3 | 0.1–0.7 | 0.004 |
| Drowsiness | 4.9 | 29.3 | 0.2 | 0.1–0.5 | < 0.001 |
| Dry mouth | 2.4 | 23.2 | 1.1 | 0.0–0.5 | < 0.001 |
| Impaired memory | 2.4 | 23.2 | 0.1 | 0.0–0.5 | < 0.001 |
| Felt more focused than usual | 1.2 | 57.3 | 0.0 | 0.0–0.2 | < 0.001 |